英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
falsi查看　falsi　在百度字典中的解释百度英翻中〔查看〕
falsi查看　falsi　在Google字典中的解释Google英翻中〔查看〕
falsi查看　falsi　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Understanding immune checkpoints and PD-1 PD-L1-mediated . . .
    Abstract Immunotherapy has emerged as a transformative approach in the treatment of various cancers, offering new hope for patients previously faced with limited treatment options A cornerstone of cancer immunotherapy lies in targeting immune checkpoints, particularly the programmed cell death protein-1 (PD-1) and programmed death-ligand 1 (PD-L1) pathway Immune checkpoints serve as crucial
  • Immune Checkpoint Inhibitors - NCI - National Cancer Institute
    Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause
  • PD-1 and PD-L1 inhibitors - Wikipedia
    The concept of blocking PD-1 and PD-L1 for the treatment of cancer was first published in 2001 [6] Pharmaceutical companies began attempting to develop drugs to block these molecules, and the first clinical trial was launched in 2006, evaluating nivolumab As of 2017, more than 500 clinical trials involving PD-1 and PD-L1 inhibitors have been conducted in more than 20,000 patients [7] By the
  • Immune Checkpoint Inhibitors and Their Side Effects
    Immune checkpoint inhibitors, like PD-1 or PD-L1 inhibitors, are treatments that help the immune system recognize and attack cancer cells Learn more here
  • Understanding PD-1 and PD-L1 in Cancer Immunotherapy
    Understanding the role of PD-1 and PD-L1 in cancer is essential to comprehend current immunotherapy strategies PD-1, a checkpoint protein on T-cells, and PD-L1, its ligand found on tumor cells, have significant implications for immune response regulation
  • PD-L1, treatment intensity, and outcomes in squamous NSCLC
    We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (NSCLC) However, PD-L1-based subgroup results reveal a critical stratification signal In patients with PD-L1 tumour proportion score
  • Assessing the Pharmacological and Pharmacogenomic Data of PD . . .
    Background Objectives: Advances in understanding immune checkpoint pathways and tumor immune biology have enabled the development of immune checkpoint inhibitors (ICIs), particularly targeting the PD-1 PD-L1 axis, which has transformed cancer immunotherapy While they have shown remarkable success in various cancer types, including melanoma, non-small cell lung cancer, and gastrointestinal
  • PD-1 and PD-L1: architects of immune symphony and . . . - Frontiers
    Recent advancements in the combination of immunotherapy with chemotherapy, radiation, and surgical procedures to enhance patient outcomes have also been highlighted Overall, this study offers an in-depth overview of the significance of PD-1 PD-L1 in cancer immunotherapy and its future implications in oncology
  • PD-L1 and PD-1: Immunotherapy Checkpoint Inhibitors
    A type of cancer immunotherapy targets PD-1 or PD-L1 with checkpoint inhibitors designed to block one or the other Learn more about testing and results





中文字典-英文字典  2005-2009